Moxifloxacin - NDC Database (Page 2)
46708-505 Feb 13, 2019
Moxifloxacin Ophthalmic Solution 5 mg/ml Ophthalmic Solution/ Drops by Alembic Pharmaceuticals Limited
Moxifloxacin Ophthalmic Solution 5 mg/ml Ophthalmic Solution/ Drops by Alembic Pharmaceuticals Limited
48792-7823 Oct 12, 2018
Moxifloxacin 400 mg Oral Tablet, Film Coated by Sunshine Lake Pharma Co., Ltd.
Moxifloxacin 400 mg Oral Tablet, Film Coated by Sunshine Lake Pharma Co., Ltd.
50090-1442 Jan 29, 2014
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
50090-4781 Feb 13, 2019
Moxifloxacin Ophthalmic Solution 5 mg/ml Ophthalmic Solution/ Drops by A-s Medication Solutions
Moxifloxacin Ophthalmic Solution 5 mg/ml Ophthalmic Solution/ Drops by A-s Medication Solutions
50090-6248 Aug 24, 2020
Moxifloxacin Ophthalmic 5 mg/ml Ophthalmic Solution/ Drops by A-s Medication Solutions
Moxifloxacin Ophthalmic 5 mg/ml Ophthalmic Solution/ Drops by A-s Medication Solutions
50090-6595 Mar 04, 2014
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
50090-6609 Mar 04, 2014
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
50090-7244 Mar 04, 2014
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
Moxifloxacin Hydrochloride 400 mg Oral Tablet, Film Coated by A-s Medication Solutions
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.